Dr Croyle Invited by Office of Counterterrorism and Emerging Threats and the Office of the Commissioner of the FDA to discuss immunological parameters in the different animal models of Ebola hemorrhagic fever that support survival from Ebola in the context of vaccine development.  She also provided the group with a summary of pre-clinical data generated for our single dose respiratory vaccine.
Talk title: "Role of the FDA Animal Rule in the Identification of Parameters Paramount to the Development of a Needle-Free Single Dose Ebola Vaccine".